Rare diseases
Investigational molecules
Locations
Back to Hungary75 clinical trials in Bekescsaba, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
HungaryA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
HungaryA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
HungaryA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
HungaryStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
HungaryStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
HungaryStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
HungaryStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
HungaryStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
HungaryHungaryStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments
HungaryLong-term safety study of tulisokibart in adults with Crohn's disease or ulcerative colitis
HungaryThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on heart failure prevention and treatment of atherosclerotic cardiovascular disease. Studies evaluate new combination therapies and interventions for reducing major cardiac events.
Several trials are investigating novel drug combinations to improve cardiovascular outcomes and patient quality of life.
Comprehensive research into inflammatory bowel conditions, including Crohn's Disease and Ulcerative Colitis. Multiple trials are evaluating new therapeutic approaches for moderate to severe cases.
Focus on long-term efficacy and safety of various treatment options for inflammatory bowel conditions.
Advanced research into dyslipidemia and hypertriglyceridemia, with trials examining new therapeutic approaches for managing blood lipid levels and associated conditions.
Studies aim to improve treatment options for patients with various metabolic disorders and associated cardiovascular risks.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
